EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Rifaximin in Patients With Monoclonal Gammopathy

Phase 1

Recruiting

Conditions: IgA Monoclonal Gammopathy
IgM Monoclonal Gammopathy
Monoclonal Gammopathy
Waldenstrom Macroglobulinemia
IgG Monoclonal Gammopathy
Light Chain Deposition Disease
Smoldering Waldenstrom Macroglobulinemia
Gammopathy Igg
Gammopathy, Monoclonal

Interventions: Drug: Rifaximin

First Posted Date: 2019-01-29

Last Posted Date: 2024-03-21

Lead Sponsor: Emory University

Target Recruit Count: 48

Registration Number: NCT03820817

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Other: Oral Glucose Tolerance Test (OGTT)

First Posted Date: 2019-01-28

Last Posted Date: 2024-05-02

Lead Sponsor: Emory University

Target Recruit Count: 12

Registration Number: NCT03818516

Locations: 🇺🇸
Emory University Clinical Research Network, Atlanta, Georgia, United States
🇺🇸
Emory Clinic, Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Department of Psychiatry and Behavioral Sciences, Atlanta, Georgia, United States

and more 3 locations

Reducing Disparities in Living Donor Transplant Among African Americans

Not Applicable

Completed

Conditions: Kidney Transplant

Interventions: Behavioral: Living ACTS website
Behavioral: Standard transplant education procedures

First Posted Date: 2019-01-28

Last Posted Date: 2024-06-06

Lead Sponsor: Emory University

Target Recruit Count: 416

Registration Number: NCT03819686

Locations: 🇺🇸
Emory Transplant Center, Atlanta, Georgia, United States

Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)

Phase 3

Completed

Conditions: Osteoarthritis

Interventions: Biological: Bone Marrow Derived MSCs
Biological: Adipose-derived MSCs
Biological: Umbilical Cord Tissue (UCT) MSCs
Drug: Corticosteroid injection

First Posted Date: 2019-01-28

Last Posted Date: 2023-07-27

Lead Sponsor: Emory University

Target Recruit Count: 475

Registration Number: NCT03818737

Locations: 🇺🇸
Andrews Institute, Gulf Breeze, Florida, United States
🇺🇸
The Emory Clinic, Atlanta, Georgia, United States
🇺🇸
Duke University, Durham, North Carolina, United States

and more 1 locations

Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer

Not Applicable

Completed

Conditions: Liver and Intrahepatic Bile Duct Carcinoma
Unresectable Pancreatic Carcinoma
Gastric Carcinoma
Unresectable Esophageal Carcinoma

Interventions: Dietary Supplement: Zinc

First Posted Date: 2019-01-28

Last Posted Date: 2024-01-17

Lead Sponsor: Emory University

Target Recruit Count: 17

Registration Number: NCT03819088

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer

Phase 2

Active, not recruiting

Conditions: Colorectal Cancer Metastatic
Colorectal Adenocarcinoma
Metastatic Microsatellite Stable Colorectal Carcinoma
Refractory Colorectal Carcinoma
Stage IV Colorectal Cancer
Stage IVA Colorectal Cancer
Stage IVB Colorectal Cancer
Stage IVC Colorectal Cancer

Interventions: Drug: Metformin
Biological: Nivolumab

First Posted Date: 2019-01-11

Last Posted Date: 2023-07-05

Lead Sponsor: Emory University

Target Recruit Count: 24

Registration Number: NCT03800602

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

2 Versus 6 Hour Oxaliplatin Infusions in Patients with Gastrointestinal Cancers

Phase 2

Active, not recruiting

Conditions: Malignant Digestive System Neoplasm

Interventions: Drug: Fluorouracil
Drug: Leucovorin
Drug: Oxaliplatin

First Posted Date: 2019-01-11

Last Posted Date: 2024-12-20

Lead Sponsor: Emory University

Target Recruit Count: 60

Registration Number: NCT03800693

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

Determining the Benefits of Improving Communication in BPAP/CPAP Users

Not Applicable

Completed

Conditions: Communication
Positive-Pressure Respiration

Interventions: Device: F2S Communicator
Other: Non-functioning Communicator

First Posted Date: 2019-01-08

Last Posted Date: 2020-09-18

Lead Sponsor: Emory University

Target Recruit Count: 36

Registration Number: NCT03795753

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Emory Clinic, Atlanta, Georgia, United States

Water Versus Saline as Irrigation Fluid for Ureteroscopy

Not Applicable

Completed

Conditions: Urolithiasis
Urothelial Carcinoma
Hydronephrosis
Ureteral Stricture

Interventions: Other: Water
Other: Saline

First Posted Date: 2019-01-04

Last Posted Date: 2019-01-04

Lead Sponsor: Emory University

Target Recruit Count: 150

Registration Number: NCT03794102

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Not Applicable

Terminated

Conditions: Chronic Inflammatory Demyelinating Polyneuropathy

Interventions: Device: Non-invasive vagus nerve stimulation (nVNS)
Other: Standard of care treatment

First Posted Date: 2018-12-11

Last Posted Date: 2023-07-14

Lead Sponsor: Emory University

Target Recruit Count: 2

Registration Number: NCT03772717

Locations: 🇺🇸
Children's Healthcare of Atlanta, Center for Advanced Pediatrics, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy